Skip to main content
Premium Trial:

Request an Annual Quote

Floragenex Lands Investment from Seed Firm

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agricultural genomics company Floragenex has received a strategic investment from Illinois Foundation Seeds, a research and licensing company focused on corn technologies.

Floragenex did not disclose the amount of the investment, which gives Illinois Foundation Seeds access to technology for research and breeding efforts in the dent corn and sweet corn markets.

Based in Eugene and Portland Ore., Floragenex has an exclusive license to restriction site associated DNA, or RAD, sample preparation and sequencing technology that was developed at the University of Oregon.

The RAD technique supports researchers seeking SNP information in species that lack assembled reference genomes.

As part of the investment agreement, Tim Johnson, division president of Illinois Foundation Seeds, will join the board at Floragenex to “provide support as the company continues to grow into new markets and reach new customers,” the company said.

Filed under

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.